Nevertheless, there are several weak points for authors to consider. First, even though the paper seems to be a data-driven paper, the lack of theoretical explanation made the testing hypotheses not so clear. Such an unclear framework led the interpretations of results to be all relevant but also to have no focuses of the paper. Second, the authors mentioned the household annual income and ethnicity are control variables on page 9, but later the authors mentioned that due to the substantial missing cases, they are not included in the main analyses. The unclear writing on the variables covered in the model seems to be contradicting. Related to the issue of missing data, it will be better that authors analyze the characteristics of the missing cases to know who are more likely to decide not to reveal the information. Those who reported the ethnicity and annual income and those who did not may be related to the heterogeneity of two different social groups in using health resources. Third, employing analyses based on the sample that provide the information of household income and ethnicity is necessary, but it should not be counted as sensitivity analyses. It should be a part of the analyses used for arguing whether it is justified to not include these two important factors. Fourth, as the authors explained that PoD that occurred in early life may impact on diseases in later stage of the life course, the analyses used in the study seem to assume that the PoD and using health resources are a linear relationship. It may ignore the fact that age and other life course factors may actually differentiated risks of diseases. The model may need to include certain interaction effects between age and PoD and other possibilities. Fifth, the results showed that those who are highly educated are more likely to have higher reimbursement. What are the possible explanations on this finding? Lastly, the analyses did not include the employment status and marital status which may influence health and wellbeing greatly. It raises doubts on whether it is justified to argue that it's the PoD that leads to the medical spending or other life-course related factors that result in these health-seeking outcomes and spending.
Introduction •
There are some terms and sentences in the introduction that make some assumptions of the readers area of expertise. Implication/Discussion While previous studies examining adverse health complications among populations with PoDs have suggested earlier screening strategies for disease prevention and healthcare management,3,13 the findings from the current study could inform decision making processes regarding private health benefit plan design and healthcare resource allocation for services and treatments by administrators and policymakers. This sentence and the entire next paragraph are confusing to me -and appear to be at odds with what you have stated in other areas of the manuscript. I believe you are specifically addressing the issues surrounding adequate transition of care for individuals with PoD from pediatric to adult healthcare. If that is the case I would reference those articles instead of the disease specific ones you have listed in 17 -20. https://www.gottransition.org/researchpolicy/index.cfm has an extensive list of resources. You do appear to be alluding to this concept throughout. The remainder of the discussion is very well written
GENERAL COMMENTS
The study concerns the impacts of pediatric-onset disabilities (PoDs) on healthcare resources. The authors argue that there is limited evidence of the healthcare burden of PoDs which limits the ability of policymakers to effectively plan healthcare needs for this population in the future. The study compares healthcare utilization and costs using a dataset of beneficiary claims covering a population of 16 million. Adjustments are made for a range of sociodemographic characteristics, insurance coverage, and for noncommunicable diseases. The authors find higher rates of healthcare utilization and costs (including out-of-pocket patient costs) for those with PoDs compared to those without. The findings suggest a need to better design insurance plans and future healthcare services for these groups.
The study covers an interesting area and is motivated well, it identifies important issues for healthcare policy and is clearly written. The authors appear to be using a valuable dataset with rich data enabling a thorough assessment of healthcare utilization and costs. There are aspects of the manuscript that I feel could benefit from further clarity and I have three more substantive suggestions relating to the methodology taken that the authors may be able to further justify (sample clarification; the motivation and use of adjustment in the analyses; and the subgroup analyses of PoDs).
Sample clarification: Page 6, line 51: The authors restrict the sample to those with at least one service utilization in 2016. It is not clear why this was done, it may bias the findings with the direction dependent on whether beneficiaries with PoDs are more or less likely to have some level of service use. Was it not possible for the authors to assign those with no service use zero values? Later on Page 8 (line12) it appears non-use is in the sample, please could this be clarified.
Adjustment in the analyses:
The manuscript may be strengthened by the inclusion of justification for adjustment (e.g. Sociodemographic variables: Page 9, line 11). The approach to adjustment also varies for utilization and cost models, is there a reason utilization models did not adjust for sociodemographic characteristics and insurance coverage? It seems at odds to adjust for costs in this way but not use of services.
Statistical analyses: Page 9, line 40: The authors adjust for noncommunicable diseases in the regression analyses of costs, currently this is not well justified (see above comment). I question whether adjustment for these diseases is the correct approach to take, this is because some of these diseases may reflect PoDs (indeed, the authors find noncommunicable diseases to be more prevalent in the PoD group (Table 1) Figure 3 , but this hasn't been tested. Further, the authors could perhaps be more cautious in claiming no single PoD diagnosis or subset of PoD are driving the results. At present there are large ratios found, the absolute variation could be very large. For example, could it be that the 7.5 times greater inpatient visits for PoDs of the circulatory and nervous system are significantly larger than the absolute variation for the other groups?
Discussion: Page 18, lines 3-26: The authors could highlight the strengths of the study here, there could also be more limitations (missing data on variables, any variables that would ideally have been adjusted for but not evident in the data, the measure for noncommunicable diseases, the areas of future research gives some further suggestions here).
VERSION 1 -AUTHOR RESPONSE
Reviewer 1 Reviewer Name: Pei-Chun Ko Institution and Country: National University of Singapore Please state any competing interests or state 'None declared': None declared Comment 1: The paper that based on the large-scale national wide dataset is one of the increasing trends to analyze national registry data. The paper that analyzed the health-service spending and health utilization between those with pediatric-onset disabilities (PoDs) and those without PoDs stands out of its important societal and scientific relevance.
• Response: Thank you for reviewing this paper.
Comment 2: Nevertheless, there are several weak points for authors to consider. First, even though the paper seems to be a data-driven paper, the lack of theoretical explanation made the testing hypotheses not so clear. Such an unclear framework led the interpretations of results to be all relevant but also to have no focuses of the paper.
• Response: Unfortunately, there is no extensive literature on the topic. However, we provide up-to-date literature on the topic throughout the manuscript (Introduction and Discussion sections) and walk the reader through how the unhealthful growth and development can increase chronic disease risk and how that might in turn impact healthcare economics (Introduction, 1st paragraph, sentence 3-5 and 2nd paragraph sentence 1). We hope our revisions to the manuscript have improved the needed framework to understand the study findings.
Comment 3: Second, the authors mentioned the household annual income and ethnicity are control variables on page 9, but later the authors mentioned that due to the substantial missing cases, they are not included in the main analyses. The unclear writing on the variables covered in the model seems to be contradicting. Related to the issue of missing data, it will be better that authors analyze the characteristics of the missing cases to know who are more likely to decide not to reveal the information. Those who reported the ethnicity and annual income and those who did not may be related to the heterogeneity of two different social groups in using health resources.
• Response: We mentioned that they were only considered for risk adjustment prior to the statistical analysis section, but upon discovering the extent of missing data on the variables, they were omitted in the primary analyses to avoid truncating our data and potentially biasing outcomes. In light of this, we performed a sensitivity analysis (noted in Statistical Analysis section, end of 2nd paragraph) and included all cases without any missing data to determine if omitting these variables biased the outcome. The results revealed that these variables and omission of them did not bias study findings.
Comment 4: Third, employing analyses based on the sample that provide the information of household income and ethnicity is necessary, but it should not be counted as sensitivity analyses. It should be a part of the analyses used for arguing whether it is justified to not include these two important factors.
• Response: The results of the primary and sensitivity analyses lead to the same conclusion. Therefore, we feel confident in the study findings and the approach taken.
Comment 5: Fourth, as the authors explained that PoD that occurred in early life may impact on diseases in later stage of the life course, the analyses used in the study seem to assume that the PoD and using health resources are a linear relationship. It may ignore the fact that age and other life course factors may actually differentiated risks of diseases. The model may need to include certain interaction effects between age and PoD and other possibilities.
• Response: This is a great suggestion, and one we gave considerable thought prior to performing analyses. Since we postulate that adults with PoDs are getting chronic diseases younger compared to the general population of adults, we might expect that the healthcare costs (our primary interest) may also be costlier at younger ages, but the magnitude of the disease and cost gap may be different across age strata. We have therefore examined an age*group interaction using the fully adjusted model with costs as the outcome for the primary analysis comparing the effect of PoD (i.e., PoD vs. non PoDs) as well as for each of the PoD categories. Given the large volume of results, we present these results in a supplementary table but provide a general conclusion from these analyses in the revised manuscript. Briefly, there were significant age*group interactions for all PoDs and for each PoD category compared to non PoDs. After stratifying by young and middle-aged, all PoDs and each PoD category had higher adjusted costs, but the magnitude of the difference was greater for young than middle-aged adults with PoDs. We have revised the statistical analysis, Results, and Discussion sections accordingly, and added a supplementary table to present the results. Thank you very much for this excellent suggestion.
• While we are cognizant of both observable and latent factors that may influence differential risk of disease, we aim in subsequent work to address this with the implementation of sub-group analysis and clinically relevant interaction terms beyond age alone (e.g., sex, education). The development of these incremental models would add substantial sub-group comparisons that are outside the scope of the main aim of the paper concerning the overall PoD effect on healthcare costs.
Comment 6: Fifth, the results showed that those who are highly educated are more likely to have higher reimbursement. What are the possible explanations on this finding? Lastly, the analyses did not include the employment status and marital status which may influence health and wellbeing greatly. It raises doubts on whether it is justified to argue that it's the PoD that leads to the medical spending or other life-course related factors that result in these health-seeking outcomes and spending.
• Response: Our primary interest was interpreting the main effect of group to examine how PoDs associate with the outcome. We have revised the statistical analysis section to emphasize this point. Since the majority of the entire sample in the statistical models included adults without PoDs, interpreting the association of education on the outcomes would primarily reflect adults without PoDs, and is out of the scope of the present work.
Reviewer 2 Reviewer Name: Prof. Dr. Olga Golubnitschaja Institution and Country: University of Bonn, Germany Please state any competing interests or state 'None declared': No competing interests.
Comment 1: The paper is well written providing important data for multi-professional consideration. However, a minor revision proposed below may further improve the overall quality of the publication.
• Response: We thank the reviewer for recognizing the importance of the work and for taking the time to provide constructive feedback.
Comment 2: To attract more attention of the relevant healthcare providers to the paper, additional keywords are strongly recommended to be provided (e.g. economic burden most relevant pathologies). To this end, some paragraphs might be useful to provide regarding the world statistics towards the most relevant pathologies accompanied by corresponding references such as -Diabetes care in figures: current pitfalls and future scenario. EPMA J. 2018;9(2). 10.1007/s13167-018-0133-y -Risks associated with the stroke predisposition at young age: facts and hypotheses in light of individualized predictive and preventive approach. EPMA J. 2019 Feb 20;10(1):81-99. doi: 10.1007/s13167-019-00162-5.
• Response: These are excellent papers. The writing was very captivating and intriguing. These papers instilled a sense of a "call to action", which provided a very exciting and engaging way to disseminate such an important topic and engender interest from multiple and diverse communities.
• We were motivated by these papers to revise the manuscript to provide keywords that could elicit interest from key stakeholders. However, we had a difficult time identifying areas in the manuscript to provide such key words and that would be consistent with the rest of the writing and study findings. Part of the reason is that this line of research, regarding health disparities among adults with pediatric-onset disabilities, is very new and we are attempting to better understand the extent of the problem of adverse health, health economics, and poor healthcare delivery for these populations. As we are in the very early stages, we prefer to present foundational findings in a more conservative manner and felt that a "call to action" style writing may be inappropriate for our current stage. However, these papers provide an excellent resource of how to engage communities, and we will certainly use this style once we have established this line of research further.
• We want to thank this reviewer for providing such excellent and exciting papers. We hope we have not disappointed this reviewer by wishing to take a more conservative approach while we start to unravel the burden of adverse health for these under-served and under-studied populations.
Comment 3: An additional section "Conclusions and Expert Recommendations" might be useful to demonstrate the "road-map" about how to move towards more positive economy of healthcare such as predictive and preventive services to young populations -see for example the below noted paper -Medicine in the early twenty-first century: paradigm and anticipation -EPMA position paper 2016. EPMA J 2016;7:23, DOI: 10.1186/s13167-016-0072-4.
• Response: Again, such a wonderful paper discussing the logistics and potential impact of predictive, preventive, and personalized medicine.
• As noted above, we are in the early phases of better understanding the burden of adverse health and health disparities for populations with pediatric-onset disabilities. This study lays the needed groundwork to perform further and deeper investigations to elucidate these problems. As such, our expert recommendations are limited due to the limited literature on this topic. Nevertheless, we provide some recommendations for further research, keeping in mind a cautious tone. For example, the end of the 3rd paragraph in the Discussion: "Nevertheless, identifying and delineating other "cost drivers" for populations with PoDs is needed." End of 4th paragraph in the Discussion: "Future research is needed to parse out the PoD-specific factors contributing to excess healthcare utilization and costs to lessen the healthcare economic burden attributable to various PoDs." Conclusions paragraph: "Future research is needed to identify specific cost drivers for the healthcare economic disparity for individuals with PoDs, and by the type of PoD, as well as year to year healthcare costs, which may provide insight into the long-term financial burden." • We have revised the Conclusion paragraph to add this reference, because it is very relevant and an excellent consideration for future directions: "Future research is also needed to develop algorithms and strategies for disease and cost prediction for these populations, which may significantly enhance preventive and personalized medicine, improve healthful aging, and reduce long-term costs.34" • We also provide how these findings could impact non-research stakeholders throughout the manuscript.
• As our team continues to build this line of research and unravel the burden of adverse health for these populations, we can start to develop more concrete opinions, directions, and needs to move towards a better healthcare economy. Thank you for providing such great feedback to improve the overall scope and impact of our work.
Reviewer 3 Reviewer Name: Jennifer Andrews Institution and Country: University of Arizona, US Please state any competing interests or state 'None declared': None declared.
Comment 1: This is a very interesting article. Thank you for addressing the topic and bringing to light some very critical areas that need to be addressed in this population. There are a number of assumptions you have made about the reader's knowledge regarding healthcare cost data and insurance categories that you will likely need to define given the broader audience for this journal. I also think that your take home points are addressing the inadequate care of children with special healthcare needs after they become adults which is well discussed problem in the US. Your findings of increased out of pocket costs and the needs for supplemental insurance in the discussion, coupled with the likelihood of inadequate ped-to-adult healthcare transition is important.
• Response: We thank the reviewer for recognizing the importance of the work and for taking the time to provide constructive feedback. We have carefully considered the reviewer's comments and have put our best effort to revise the manuscript based on their suggestions.
Comment 2: Rationale for the manuscript is to detail the costs incurred for adults with PoD for care to provide a baseline for health care reform to improve outcomes and reduce costs in this population in the future.
• Response: This is an excellent summary of our rationale.
Comment 3: There are some terms and sentences in the introduction that make some assumptions of the readers area of expertise. Children with disabilities often get treated by several doctors which increases the risk of miscommunication across doctors and specialists to provide specific health services or medications to these children.
• Line 31: financial, time, and health. • Line 33: There is an increasing incidence of PoDs over the past several decades, and while life expectancy is getting longer for these individuals, mortality is still earlier than the general population. The result is more PoDs that are older and sicker than in previous decades.
• Lines 45-49: The current U.S. healthcare system is not adequately prepared to care for adults with PoDs because little is known about the natural trajectory of adverse health complications across the lifespan for these populations ("life-course health development"), coordinating healthcare services between general physicians and specialists ("care coordination"), and providing adequate resources for preventive and treatment services ("healthcare accessibility"). To improve clarity, we have revised this sentence as follows: "The current U.S. healthcare system may not be adequately prepared to care for adults with PoDs.17-20 To date, little is known about the natural trajectory of adverse health complications across the lifespan for these populations, best practices for coordinating healthcare services between general physicians and specialists (e.g., pediatricians), and how to provide adequate resources for preventive and treatment services to these populations." • Page 2 Line 8: This is an excellent suggestion. We have revised the text to this comment. This fits more in line with the scope of the current work. Thank you.
Comment 4: Data source -you should define Medicare advantage health plans for those readers who are not informed about US health insurance categories.
• Response: Great suggestion. We have now briefly defined Medicare Advantage in the revised text as follows: "This database contains over 16 million beneficiaries in 2016 who have either commercial or Medicare Advantage health plans, and includes all the inpatient, outpatient, pharmacy, emergency visit, office visit, and other ancillary service utilization throughout their enrollment on the insurance plan. Medicare beneficiaries can opt to enroll in a private Medicare Advantage health plan in lieu of participating in the traditional public Medicare program. Such plans can offer extra coverage not available in the traditional Medicare program, such as vision, hearing, dental, and/or health and wellness programs." Comment 5: You have two sets of visit categories that mostly overlap but contain some differences. Supplementary table 2 needs to be a primary table unless you feel the audience for this journal is well-versed in insurance industry billing categorizations.
• Response: The type of service codes are proprietary codes assigned for the services at the time the services are performed by a single, U.S., private payer. To be consistent with the database, we used their categorization scheme for service categories. We wondered if our table format may have led to confusion. Therefore, we have added lines to differentiate the service categories. A copied version of the table is below this response. The level 2 description is how we organized the service categories. So, while "Facility Outpatient" is in both the 2nd and 3rd row, the specific service is different and within their respective place holder.
• Response: Our collective work on the topic is detailing the extent of health disparities, their causes, and risk factors for these under-represented sectors of the population. We chose to group PoDs by body system to be consistent with our previous work currently under review and in press as we show that chronic diseases of that body region tend to be highest among PoDs of that same biological system. For example, musculoskeletal PoDs have higher rates of osteoporosis and osteoarthritis; circulatory PoDs have higher rates of cardiovascular diseases; kidney/urinary PoDs have higher rates of kidney diseases, etc.
• Currently, there is not much work to date studying multiple PoDs. We hope that our research will start to carve out paths to better identify, group, and define these conditions. Comment 7: Healthcare resource utilization section -patients per group (with PoDs, without PoDs) that had at least one service utilization for each service category -one visit within any service category or one within each?
• Response: This is one visit within each service category. We now see how our original writing lead to this confusion. We have revised the sentence and replaced "for" with "within." It now reads: "Measures to assess healthcare resource utilization included the percentage of patients per group (with PoDs, without PoDs) that had at least one service utilization within each service category, and…" • Thank you for pointing this out.
Comment 8: Assuming there were no low cost outliers?
• Response: There were no negative values and the statistical models were purposefully selected as they account for outliers common to cost data. Further, the distribution showed a positive skew and not a negative skew, which is consistent with cost data which generally has a long right tail.
Comment 9: Healthcare costs -You list a number of things here that are not universally known. E.g. insurer payments, patient paid amounts vs. patient out-of-pocket.
• Response: We realize that we are submitting to a journal that is not based in the U.S. and that the terms may be confusing. We therefore provided the detailed information but summarize the outcome variables as total rather than the partitioned variables that make up the total. We hope that by providing in depth detail and a summary outcome measure, that all readers with different backgrounds can understand what we are measuring and the take home message.
Comment 10: Price standardization algorithm is unclear -did you do this or is it part of the dataset? • Response: The company does this. We have revised the first sentence to improve clarity: "Clinformatics® Data Mart Database accounts for differences in pricing across health plans and provider contracts by standardizing cost field utilized algorithms that reflect the allowed payments across all provider services."
Comment 11: Group descriptives reported similarities and differences assessed statistically? If yes, include significant results with footnote in table. If no, why not?
• Response: Since the sample is so large, we may find statistical differences that are not clinically meaningful. It is not uncommon for such large datasets like this to not perform statistical analyses to determine group differences in descriptive characteristics between groups, especially when the primary analyses statistically adjust for these variables.
• Nevertheless, we appreciate this reviewer's comment. We now provide p-values for the differences in groups for descriptive characteristics. All group comparisons were found to be statistically significant at a p-value of <0.001. We carefully presented this information in the revised 1st paragraph of the Results to note considerable differences, such as the proportion in Medicare Advantage plans and prevalence of noncommunicable diseases. We hope that inclusion of the pvalues and our cautious presentation of the results is satisfactory.
Comment 12: While previous studies examining adverse health complications among populations with PoDs have suggested earlier screening strategies for disease prevention and healthcare management,3,13 the findings from the current study could inform decision making processes regarding private health benefit plan design and healthcare resource allocation for services and treatments by administrators and policymakers. This sentence and the entire next paragraph are confusing to me -and appear to be at odds with what you have stated in other areas of the manuscript. I believe you are specifically addressing the issues surrounding adequate transition of care for individuals with PoD from pediatric to adult healthcare. If that is the case I would reference those articles instead of the disease specific ones you have listed in 17 -20. https://www.gottransition.org/researchpolicy/index.cfmhas an extensive list of resources. You do appear to be alluding to this concept throughout.
• Response: Those studies (refs 3 and 13) are from our team and highlight a profound noncommunicable disease and multimorbidity prevalence among adults with cerebral palsy (a type of PoD) compared to the general population. We recommended earlier screening and preventive services for noncommunicable diseases for this population. The current study largely adds to this notion by highlighting that other PoD populations have increased risk for early development of noncommunicable diseases and that healthcare costs are very high, even after adjusting for these costly chronic diseases. Therefore, this new addition to the literature may engender interests not just from the clinical community, but now from the health plan administrators and policymakers that may be more interested in costs and other economic measures.
• We very much appreciate this comment as we can see how the next paragraph is confusing. We meant to summarize that adults with PoDs have higher prevalence of noncommunicable diseases, and how these and other non-health factors could lead to a worsening of health status and excess costs. Because we already say these comments in the Introduction and the 1st paragraph in the Discussion, we have now omitted the entire 2nd paragraph. With this revision, we are not repeating ourselves and get right into the main findings of the current study.
• We hope this revision clarifies the scope and dissemination of the current study.
Comment 13: The remainder of the discussion is very well written.
• Response: Thank you for the positive feedback.
Reviewer 4 Reviewer Name: Walter Lehmacher Institution and Country: Uni Köln Please state any competing interests or state 'None declared': 'None declared Comment 1: All relevant comparisons in the summary are expressed only by mean differences and cost ratios. I suggest to insert some information from figure 1 and 2 concerning the direct means of the cost per group. This give the reader a clearer picture of the amount of the reported differences.
• Response: This is an excellent suggestion. We have included the direct means of the cost per group in the Abstract. Thank you.
Reviewer 5 Reviewer Name: William Whittaker Institution and Country: University of Manchester, UK Please state any competing interests or state 'None declared': None declared Comment 1: The study concerns the impacts of pediatric-onset disabilities (PoDs) on healthcare resources. The authors argue that there is limited evidence of the healthcare burden of PoDs which limits the ability of policymakers to effectively plan healthcare needs for this population in the future. The study compares healthcare utilization and costs using a dataset of beneficiary claims covering a population of 16 million. Adjustments are made for a range of sociodemographic characteristics, insurance coverage, and for noncommunicable diseases. The authors find higher rates of healthcare utilization and costs (including out-of-pocket patient costs) for those with PoDs compared to those without. The findings suggest a need to better design insurance plans and future healthcare services for these groups.
• Response: This is an excellent summary of our work. We thank the reviewer for taking the time to provide constructive feedback. We have carefully considered the reviewer's comments and have put our best effort to revise the manuscript based on their suggestions.
Comment 2: The study covers an interesting area and is motivated well, it identifies important issues for healthcare policy and is clearly written. The authors appear to be using a valuable dataset with rich data enabling a thorough assessment of healthcare utilization and costs. There are aspects of the manuscript that I feel could benefit from further clarity and I have three more substantive suggestions relating to the methodology taken that the authors may be able to further justify (sample clarification; the motivation and use of adjustment in the analyses; and the subgroup analyses of PoDs).
• Response: Thank you for the positive comments and recognizing the importance of this work. Your suggested revisions have improved the scope of the work.
Comment 3: Sample clarification: Page 6, line 51: The authors restrict the sample to those with at least one service utilization in 2016. It is not clear why this was done, it may bias the findings with the direction dependent on whether beneficiaries with PoDs are more or less likely to have some level of service use. Was it not possible for the authors to assign those with no service use zero values? Later on Page 8 (line12) it appears non-use is in the sample, please could this be clarified.
• Response: Since group allocation requires a medical diagnosis in the claims, beneficiaries needed to have at least one service utilization to be given the chance to get flagged for a PoD. Otherwise, we were unable to determine any medical conditions. Based on this reviewer's comment and to enhance clarity, we have revised this sentence to: "Beneficiaries that were 18 to 64 years of age, had 12 full months of continuous enrollment, and had at least one service utilization in 2016 (to make a diagnosis of PoDs and noncommunicable diseases) were considered for this investigation." • We have now noted this as a limitation in the revised Limitations section as follows: "Second, the present study excluded individuals that did not have service utilization in 2016, which may have biased results. However, these excluded individuals that had insurance coverage may be somewhat healthier since they did not require a medical encounter in 2016, thus potentially biasing results in the present study to be more conservative estimates." • The comment regarding non-utilization later in the manuscript refers to the statistical test stratified by the specific service type, such as inpatient or outpatient. All included participants had to have at least one service utilization of any type, but not all had service utilization of all types.
• We hope this revision and clarification improves clarity.
Comment 4: Adjustment in the analyses:
• Response: The reason for adjusting for sociodemographic variables was to be sure that the findings were not tied to age, sex, etc. We have revised the manuscript to the following: "Age, sex, ethnicity, education level, household annual income, and insurance coverage (i.e., commercial only, Medicare Advantage) were considered for risk adjustment to differentiate the effect of potential confounders from the effect of PoDs on the outcome." • This is an excellent point. Our primary interest was adjusting costs. However, we can easily adjust the utilization data for these measures. We have performed these analyses and updated the manuscript and tables accordingly. Specifically, we have edited the statistical analysis section, the Results section, and the corresponding table. We found that all service utilization was significantly higher even after adjusting for age, sex, education, insurance coverage, and noncommunicable diseases (all p<0.001). Thank you for this comment as this makes the analytic approach more consistent and cohesive.
Comment 5: Statistical analyses: Page 9, line 40: The authors adjust for noncommunicable diseases in the regression analyses of costs, currently this is not well justified (see above comment). I question whether adjustment for these diseases is the correct approach to take, this is because some of these diseases may reflect PoDs (indeed, the authors find noncommunicable diseases to be more prevalent in the PoD group (Table 1 ) and refer to evidence regarding this on Page 15, line 54). Adjusting for these may underestimate the estimates for PoD as noncommunicable diseases may lie on the causal pathway.
• Response: We provide the unadjusted results to highlight the difference between groups to avoid any confusion about estimates. The results show a large difference between groups. Because adults with PoDs also have a higher prevalence of several noncommunicable diseases, which themselves incur excess costs independent of a PoD diagnosis, we thought that accounting for these costly diseases would explain a large amount of the variance between groups. If so, this could be very beneficial information for policymakers and health plan administrators, in that focusing on preventing these diseases and treating them could lead to substantial long-term cost savings; although, longitudinal analyses and forecasting models would need to confirm this.
• However, what we found was that the demographics and noncommunicable diseases only accounted for a small portion of the variance in costs between groups. This certainly prompts more research into why there is such a difference even after adjustments, in which we provide some future directions and possibilities in the Discussion. This is an important takeaway from the current work, which is why we believe that the analytic approach is well suited.
• We understand that we failed to mention this key point in the statistical analysis section. We have therefore added the following sentence after explaining the model adjustments to enhance clarity: "We adjusted the model for the noncommunicable diseases because these diseases can incur excess healthcare utilization and costs, which may explain any differences in costs between groups." This revision certainly clarifies the reason for these adjustments and strengthens the scope of the work. We thank the reviewer for pointing this out.
Comment 6: PoD subset analyses: Statistical analysis: Page 10, line 6: It is unclear why statistical comparisons of utilization and costs were not performed for the PoD stratified analyses or why adjustment wasn't made -the ability to do so is there, a stronger rebuttal may be needed here. Perhaps worth noting that a significant amount of the discussion (Page 17) is devoted to this analysis.
• Response: This is an excellent point. We merely meant to limit the number of overall statistical analyses. However, we understand the importance of testing the differences since our discussion focuses on the stratified PoD analyses.
•
We have now performed such analyses and found that all PoD categories had higher adjusted costs and most PoD categories had higher adjusted utilization (adjusted for age, sex, education, insurance coverage, and noncommunicable diseases). We have revised the manuscript accordingly in the statistical analysis section, results, tables, and figure legends. Thank you very much for this comment as it certainly strengthens the study findings.
Comment 7: Title: Could the title reflect the setting and study type (cohort or observational study)?
• Response: We have edited the title to: "The economic burden of pediatric-onset disabilities among young and middle-aged adults in the United States: A cohort study of privately insured beneficiaries." Thank you for this suggestion.
Comment 8: Abstract: The abstract currently does not detail the setting.
• Response: The setting is the nationwide private payer system. However, we did not mention the country. We have revised the setting to include the "U.S."
Comment 9: Strengths and limitations of this study: For greater clarity, the authors may wish to consider changing the first bullet point to 'This is the largest study to date to examine healthcare utilization and associated costs of adults with different types of pediatric-onset disabilities'.
• Response: This is an excellent suggestion. We have included this in the revision. Thank you.
Comment 10: Methods: Page 6: A short description of the setting early in the methods section would help provide context for the dataset used. For example, it may be helpful to inform the reader about coverage of the population, to provide reassurance that the population under this cover are generalizable and/or to highlight any national policies that mean insurance cannot be made conditional on PoD status.
• Response: This is an excellent comment. We have revised the 1st paragraph of the Methods Data Source paragraph to inform the reader about coverage for the population. In the Discussion section, we talk in detail about how our PoD population is reflected in the Optum database. We hope these revisions provide a better understanding of the setting, data, and interpretations. • Response: We agree. The statistical models and approach are inherently complex and not friendly to a general audience. We have revised the statistical analysis section to be more sensitive for a general audience, but were limited in what we could revise to not lose integrity of disseminating our research approach. We looked at recent articles including cost-related studies published by BMJ Open to get a sense of the level of complexity of their analytic section, and it appears that our revised version is not any more difficult than other publications with more complex statistical designs.
• Nevertheless, this reviewer brings up an important point and we do not wish to deter readers from viewing our manuscript. We will therefore leave it up to the handling Editor for further guidance on simplifying the statistical analysis section to accommodate the BMJ Open readership.
Comment 13: Methods: Statistical analysis: Page 10, line 8: As statistical analysis is not currently performed on the PoD stratified data it would be clearer to provide the details of statistical package and effect estimates in a separate paragraph to save confusion.
• Response: Done.
Comment 14: Methods: Noncommunicable diseases: Page 7: The presence of noncommunicable diseases appears to be based on a claim being made (Page 7, line 33), this may be a poor proxy for prevalence, it may strengthen this section to clarify that the data does not include existing health problems (or does it?).
• Response: This is an excellent comment. We did not think about our international audience when writing this section. Administrative claims data are primarily used for medical reimbursement purposes. The data are derived from codes entered into the database by healthcare providers to bill the beneficiaries of the private insurer for health services. In order to access information regarding the presence of medical conditions, we leveraged the data to identify medical conditions, including noncommunicable diseases.
• We have revised the manuscript to be more clear about the dataset and how these data can be derived. In the 1st paragraph of the Methods section, we have added the following sentence: "Administrative claims data are primarily used for billing reimbursement purposes, and health conditions are identified using specific codes attached to individual claims." Thank you very much for bringing this to our attention.
Comment 15: Methods: Healthcare resource utilization: Page 8, lines 11-22: These methods could be detailed under the statistical analyses section of the manuscript.
Comment 16: Results: Table 1 : There is a difference in insurance coverage that is not discussed.
• Response: It is now discussed in the revised Results section. Thank you for pointing that out.
Comment 17: Results: In general the presentation of the results is slightly confusing, the mixture of graphs and tables and in-text only results make comparisons difficult. Figure 1 contains limited value beyond that that could be captured in a table.
• Response: Since we have a high volume of findings, we aimed to represent our primary findings in figures and tables in order to not overwhelm the reader and prioritize our take home message. The healthcare resource utilization metrics were a means to better understand the total costs, which is why these results were placed only in the text. We understand that there are personal differences on how data should be presented. Our team feels strongly that the unadjusted cost data is best represented in a figure to really highlight the difference in cost between groups.
• We have also revised the structure of the Results section and provide subheaders to improve clarity for the reader, e.g., "Healthcare costs for adults with and without PoDs" Comment 18: Results: Tables 2 and 3: could the authors include the sample size for each regression please.
Comment 19: Results: Page 14, line 37-55: Supplementary table 3 contains the rate of use for PoD subsets while the text refers to odds, note it is not clear how these are calculated from the description of the statistical analysis there is no discussion of presenting odds.
• Response: We really appreciate this comment. We merely meant to provide a measure to represent the magnitude of difference as the PoD value / the control value. We did not perform statistical analyses or develop logistic regression models. For simplicity, we have now edited the supplementary table (now supplementary Table 2 following revisions) and included the values for the group without PoDs so that the reader can better understand the differences.
• Based on this reviewer's suggestions, we have performed statistical analyses and present this information in the table, text, and figure legends where appropriate. Specifically, we adjusted for age, sex, education, insurance coverage, and all of the noncommunicable diseases. All costs data were higher for all PoD categories compared to individuals without PoDs (all p<0.001). Most utilization measures were also higher following adjustments for most PoD categories.
• We believe that these revisions have significantly improved the study findings from this section, and we sincerely thank the reviewer for this comment.
Comment 20: Discussion: Page 15, lines 29-35: The claims that the main findings are evident across PoD categories stems from Figure 3 , but this hasn't been tested. Further, the authors could perhaps be more cautious in claiming no single PoD diagnosis or subset of PoD are driving the results. At present there are large ratios found, the absolute variation could be very large. For example, could it be that the 7.5 times greater inpatient visits for PoDs of the circulatory and nervous system are significantly larger than the absolute variation for the other groups? •
Response: We have now tested this assumption and the assumption is supported by statistically significant differences. Again, we would like to thank this reviewer for the suggestion which strengthens the findings and scope of the work.
• This is an excellent point. We have omitted that part of the sentence to provide a more cautious interpretation. Thank you.
Comment 21: Discussion: Page 18, lines 3-26: The authors could highlight the strengths of the study here, there could also be more limitations (missing data on variables, any variables that would ideally have been adjusted for but not evident in the data, the measure for noncommunicable diseases, the areas of future research gives some further suggestions here).
• Response: We have included a small strengths paragraph in the revised manuscript.
•
We have significantly expanded our Limitations section with assistance by the comments of this and other reviewers as follows: "Second, the present study excluded individuals that did not have service utilization in 2016, which may have biased results. However, these excluded individuals that had insurance coverage may be somewhat healthier since they did not require a medical encounter in 2016, thus potentially biasing results in the present study to be more conservative estimates. Third, data were from a single year and longer study periods and longitudinal research designs could provide more robust findings and implications for research, practice, and policy. Fourth, we were only able to adjust for a limited set of covariates, and we are unable to rule out other potential confounding factors. Fifth, we used a single claim to identify PoDs and noncommunicable diseases. Validation studies tend to show that two or more claims for a medical condition improves ability to identify individuals with that condition.34,35 However, single claim-based algorithms using claims data have moderate-to-high positive predictive value (~80%) and high sensitivity (99%) to detect PoDs,34 and moderate-to-high sensitivity (up to 99%) and specificity (up to 87%) to detect a variety of costly noncommunicable diseases;36,37 although, the accuracy of medical condition identification using claims data depends on the length of the study period38 and the condition examined.34,36,38,39 Given the short study period of 12 months to extract data and the large and robust effect sizes, the selected methodology to identify associations is likely sufficient to provide evidence of health and economic disparities." • We provide further research directions in the Conclusions paragraph. 
GENERAL COMMENTS
The study sought to address a gap in the literature regarding the economic impacts of pediatric-onset disabilities (PoDs) in adults. Using data from a claims database in the US the authors identify PoDs in claimants aged between 18-64 via ICD-10-CM diagnosis codes. Utilization and costs were compared between those with and without a PoDs diagnosis with adjustment made for sociodemographic characteristics and noncommunicable diseases. Adults with PoDs were found to have greater utilization and healthcare costs (both reimbursement and out-of-pocket).
Thanks to the authors for their revisions and well detailed responses, I feel the manuscript is clearer and I continue to feel the manuscript is an important piece of work. Below I cover a reassessment of the manuscript given the changes.
The study topic is well motivated. Data concerns claims to a single private payer that covers over 16m beneficiaries in the US. The authors have detailed the data well and as someone unfamiliar with the health system I can now understand the context and data much better. Thank you.
Beneficiaries are included in the data provided they have some utilization of healthcare services throughout 2016. To this extent there are potential issues of generalizability to those with no service use -prevalence of service use may be different between the two groups. However, it is not possible to identify PoDs without service use. The expansion in the discussion in the revised manuscript helps highlight this, thank you.
The measures of utilization, approach to costs and use of confounding factors all appear sensible and well documented. The statistical analysis includes univariate and multivariable analyses. The analyses appear appropriate and has taken into consideration the nature of outcome measures (e.g. count data, binary specifications). The consistency in analyses between utilization and costs in the revised manuscript is helpful.
A couple of minor suggestions regarding the methods section:
• Page 10, line 24: A minor comment, this section reads as though the Chi-Square tests adjusted for factors but my understanding is that this is not the case. It may be more transparent if the authors could mention the Ch-Square assessments were for the unadjusted analyses? • Page 10, lines 38-42: I struggled again here to see the justification for adjusting for noncommunicable diseases, at present the sentence here seems to me to be exactly what the authors are looking to understand as the aim of the paper -the additional costs and utilization of services for those with PoDs, given noncommunicable diseases are associated with PoDs it seem strange to adjust for them unless the authors are interested in the impact of PoDs beyond an increasing presence of noncommunicable diseases? May just need a little bit of explaining when first discussed in this section as the rationale is a little clearer later in the manuscript (Page 17, line 52).
• Page 11, lines -12: May help to justify the stratification a little bit here -e.g. to inform whether there is variation in the effects of different PoDs we… • Page 11, line 15: Sorry, another very minor comment, 'to determine if age differentially associated' -perhaps include 'was'
The results section is easy to follow but I feel there are a couple of ways in which the results could be presented more clearly, mostly these concern a need for a full set of estimation results either in the manuscript of as supplementary material: • Page 13, lines 20-40: Given the utilization analyses is upfront as a primary outcome it may be preferred to include the estimates from the regression analyses, even if only as supplementary material.
• Page 13, lines 20-40: It was not clear to me what the + and -were reflecting (95% CI?), note also the inconsistency with how these are presented compared to how the cost estimates are presented (from Page 13, line 54).
• Page 16, line 24: It would be more informative if Supplementary Table 2 contained the adjusted estimates. It would also be informative to provide the cost estimates too at supplementary material. At present all the reader can obtain from these sections are that some are insignificant and some aren't but no discussion on scale.
• Supplementary Table 3 : it is not clear whether the estimates here come from two regressions or four. If four then the age*interactions footnote may be misplaced here or better described as being a precursor to the analyses. If two, then could the authors explain how they obtained the CRs for the two groups given the presence of an interaction term here. In the text it looks like it's from four regressions.
• Page 17, line 4: The authors may want to be cautious about inferring relative size differences between regressions given this has not formally been tested, perhaps replace '…CR being greater' with 'CR suggesting costs may be…'. Note this also may apply to Page 17, lines 12-35 too.
The discussion is well detailed and contains useful expansions regarding strengths and limitations.
Abstract: Primary and secondary outcome measures: Currently it is unclear whether the utilization analyses was provided before and after adjusting. The authors may want to rewrite this to something like: "Annual all-cause healthcare resource utilization and total healthcare costs were compared between adults with and without PoDs before and after adjusting for sociodemographics and several costly noncommunicable diseases." Thanks again to the authors for this interesting paper.
VERSION 2 -AUTHOR RESPONSE
Reviewer 5 Comment 1: The study sought to address a gap in the literature regarding the economic impacts of pediatric-onset disabilities (PoDs) in adults. Using data from a claims database in the US the authors identify PoDs in claimants aged between 18-64 via ICD-10-CM diagnosis codes. Utilization and costs were compared between those with and without a PoDs diagnosis with adjustment made for sociodemographic characteristics and noncommunicable diseases. Adults with PoDs were found to have greater utilization and healthcare costs (both reimbursement and out-of-pocket).
 Response: Once again, this is an excellent summary of our work. We thank the reviewer for taking the time to provide constructive feedback. We have carefully considered the reviewer's comments and have put forth our best effort to revise the manuscript based on their suggestions.
Comments 2-5:
 Response to Comment's 2-5: We are very pleased the work is easier to comprehend and we thank this reviewer for the kind words. Thanks to this reviewer and other reviewers, we too believe this manuscript is much stronger.
Comment 6: A couple of minor suggestions regarding the methods section:
Page 10, line 24: A minor comment, this section reads as though the Chi-Square tests adjusted for factors but my understanding is that this is not the case. It may be more transparent if the authors could mention the Ch-Square assessments were for the unadjusted analyses?
 Response: We agree that the way we presented it does make it seem as though our ChiSquare tests are for adjusted analyses, which they are not. We have revised this sentence to the following: "Group differences for healthcare resource utilization measures were examined using Chi-Square tests for unadjusted analyses of binary data…" Thank you for this comment.
Comment 7: Page 10, lines 38-42: I struggled again here to see the justification for adjusting for noncommunicable diseases, at present the sentence here seems to me to be exactly what the authors are looking to understand as the aim of the paper -the additional costs and utilization of services for those with PoDs, given noncommunicable diseases are associated with PoDs it seem strange to adjust for them unless the authors are interested in the impact of PoDs beyond an increasing presence of noncommunicable diseases? May just need a little bit of explaining when first discussed in this section as the rationale is a little clearer later in the manuscript (Page 17, line 52).
 Response: For the unadjusted analyses, we were interested in determining the effect of PoDs on the outcomes. However, given the burdensome medical profiles (e.g., noncommunicable diseases) experienced by individuals with PoDs throughout the lifespan, one may easily speculate that the higher costs are driven by the greater prevalence of noncommunicable diseases. As we anticipated this prior to starting the work, we performed an additional step to determine how much of the noncommunicable disease prevalence accounted for the higher utilization and costs. We found that noncommunicable diseases accounted for very little of the variance, which is an important finding.
 We are pleased that the reviewer was satisfied with our rational in the Discussion. Based on this reviewer's comment, we have revised the Statistical Analysis section to be more clear as to the rational early on: "We adjusted the models for the noncommunicable diseases to determine the effect of PoDs on the outcome beyond the presence of these diseases, because they can incur excess healthcare utilization and costs which may explain any differences in costs between groups." Comment 8: Page 11, lines -12: May help to justify the stratification a little bit here -e.g. to inform whether there is variation in the effects of different PoDs we…  Response: This is an excellent suggestion. We have revised the first sentence to the following: "To determine whether there is variation in the effect of different PoD categories, healthcare resource utilization and total cost measures were summarized using mean ± SD after stratifying the type of PoD (e.g., musculoskeletal system, neurodevelopmental)."
Comment 9: Page 11, line 15: Sorry, another very minor comment, 'to determine if age differentially associated' -perhaps include 'was'  Response: We have made this change.
Comment 10: The results section is easy to follow but I feel there are a couple of ways in which the results could be presented more clearly, mostly these concern a need for a full set of estimation results either in the manuscript or as supplementary material:
Page 13, lines 20-40: Given the utilization analyses is upfront as a primary outcome it may be preferred to include the estimates from the regression analyses, even if only as supplementary material.
 Response: We have now included the estimates from the regression analyses in Supplementary  Response: This paragraph is presenting unadjusted data. The ± reflects the mean plus/minus the SD since this is count data. We have noted this presentation of the data in the 1 st sentence of the 2 nd paragraph within the Statistical Analysis section: "Descriptive characteristics and healthcare resource utilization and cost measures were summarized using mean (SD) for continuous variables and percentage for categorical variables." However, perhaps the lack of the plus/minus sign early on caused some confusion. We have therefore revised this sentence to the following: "Descriptive characteristics and healthcare resource utilization and cost measures were summarized using mean ± standard deviation (SD) for continuous variables and percentage for categorical variables."
 To further improve clarity, we have revised the Results section to remind readers how this count data is presented prior to the first values: "Individuals with PoDs had greater unadjusted annual mean count of service utilization compared to individuals without PoDs (presented as mean ± SD) for inpatient visits (1.0 ± 2.4 vs. 0.2 ± 1.2), outpatient and other visits (14.7 ± 13.4 vs. 7.1 ± 8.9),…"
 We hope these revisions improves clarity.
Comment 12: Page 16, line 24: It would be more informative if Supplementary Table 2 contained the adjusted estimates. It would also be informative to provide the cost estimates too at supplementary material. At present all the reader can obtain from these sections are that some are insignificant and some aren't but no discussion on scale.
 Response: In response to "It would be more informative if Supplementary Table 2 contained the adjusted estimates. It would also be informative to provide the cost estimates too at supplementary material."
o While we certainly appreciate the logic behind this comment, we have ultimately chosen not to accommodate this suggestion for 2 reasons, which we hope this reviewer can understand.
o First, we wanted to present our data as simply as possible given that our primary audience will likely be clinicians and policymakers that may not appreciate the nuanced interpretation of the adjusted models. Our analytic approach is already somewhat complicated (as this reviewer has pointed out in the first revision) for a statistical lay audience that would benefit from this knowledge (e.g., clinicians, policymakers). Presenting the unadjusted results provides a raw and easily interpretable magnitude of difference. We further present p-values to determine if this difference remains after adjusting for confounders. Our team includes a clinician, economist, health services researchers, and a biostatistician. In our collective experience, we agree that the simpler dissemination will result in greater impact, understanding, and utilization from our target audience.
o Second, to be consistent with a simpler and focused delivery of our main message, we wish to avoid excess volume of analyses. We currently have 4 tables, 2 figures, and 4 supplementary tables with most presentation formats containing a large amount of data. We are therefore reluctant to add more tables for data that is already presented in such a way that is easily interpretable in order to avoid readers getting overwhelmed with the number of analyses and results.
o We sincerely apologize about not wishing to accommodate this suggestion from the reviewer, who has obviously worked very hard to provide us with constructive suggestions aimed towards improving the manuscript. We hope that our explanation helps to reiterate that we merely wish to keep our main message focused and easily interpretable so that readers can digest this information.
 In response to "At present all the reader can obtain from these sections are that some are insignificant and some aren't but no discussion on scale." o This reviewer may be inquiring about why we did not present data within the text as we did with the analyses concerning PoD vs. non PoD. Since most conclusions for utilization and all conclusions for cost comparisons followed the same pattern for individual PoD categories compared to non PoD as the comparisons between the entire PoD vs. non PoD groups, and that these analyses were secondary to the main aim and focus of the paper, we only present data in the tables and figures to limit the volume of the manuscript (reaching the limit allowed by the Journal) and improve readability.
Comment 13: Supplementary Table 3 : it is not clear whether the estimates here come from two regressions or four. If four then the age*interactions footnote may be misplaced here or better described as being a precursor to the analyses. If two, then could the authors explain how they obtained the CRs for the two groups given the presence of an interaction term here. In the text it looks like it's from four regressions.
 Response: Results in this Supplemental Table are from four regression analyses. We now understand how our footnote may have led to confusion. Since we document the significant age x group interaction in the text, we have removed the footnote in Supplementary Table 3  (now Supplementary Table 4) . Thank you for pointing this out.
Comment 14: Page 17, line 4: The authors may want to be cautious about inferring relative size differences between regressions given this has not formally been tested, perhaps replace '…CR being greater' with 'CR suggesting costs may be…'. Note this also may apply to Page 17, lines 12-35 too.
 Response: This is an excellent suggestion. We have revised accordingly.
Comment 15: The discussion is well detailed and contains useful expansions regarding strengths and limitations.
 Response: Thank you for this comment and the original comments that improved the Discussion section.
Comment 16: Abstract: Primary and secondary outcome measures: Currently it is unclear whether the utilization analyses was provided before and after adjusting. The authors may want to rewrite this to something like: "Annual all-cause healthcare resource utilization and total healthcare costs were compared between adults with and without PoDs before and after adjusting for sociodemographics and several costly noncommunicable diseases."
